Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
cannabinoids - search results
If you're not happy with the results, please do another search
Gregory Land – Canna CBD
Gregory Land Chief Executive Officer at Canna CBD.
Industrial hemp: Part of the cannabis sativa family
Henri Sant-Cassia from CBD Virtue turns the spotlight onto industrial hemp, a part of the cannabis sativa family.
Regulation and quality control for the medical cannabis industry
AlphaCAT (Cannabinoid Analysis Test) takes the first step to regulation and quality control for the medical cannabis industry, as this profile by the firm’s Sebastien Beguerie sheds light on.
Europe setting standards for cannabis products
As government authorities come to grips with legislation of cannabis-based products, the European market holds a key position, Liam McGreevy, CEO, Ethnopharm Ltd explains.
Cannabis products: Greater diversity, increased potency and close monitoring
A recent European Monitoring Centre for Drugs and Drug Addiction report highlights the need for diversity of cannabis products, increased potency and close monitoring of health effects.
The cannabis industry in the UK: Risky business?
Is the cannabis industry in the UK a risky business? John Binns, Partner at BCL Solicitors LLP finds out more.
CBD: A brief introduction to a brand-new industry
Mile High Labs International Limited provides a brief introduction to a brand-new industry, CBD, a non-psychoactive cannabinoid.
Fundación CANNA: Promoting research, scientific studies and cannabis analysis
Here, we find out about Fundación CANNA’s aim is to promote research and education about cannabis, including their strong focus on the effects of this on the human body.
UK and Ireland medical cannabis access programmes and education slowly progress
GreenLight Pharmaceuticals Ltd is advancing clinical research and education in UK and Ireland; Though government progress on access and prescribing recommendations lags behind much of Europe.
Can you take too much CBD?
Whether you see it as the “latest” health craze, have considered taking it yourself, or, have been relying on it for some time now, you may have asked: Can someone take too much CBD? Here, we find out.
CBDepot: Producing cannabinoid ingredients
CBDepot, a pioneer in the production of high-quality natural cannabinoid ingredients and a world-leading researcher highlights the work they conduct here.
Can CBD be effective in supporting your mental health?
Sophia Ali co-founder of Amma Life shares her views on supporting your mental health through the use of CBD oil and other methods, here.
Is CBD oil safe and what are the benefits?
Here, experts from Charlotte's Web discuss everything you need to know about the effectiveness, safety and benefits of CBD oil.
Beyond pain relief and mental health: The science behind CBD oil
Snoring? Dry skin? Sleeplessness? Eczema? Inflammation? Studies continue to explore the benefits of CBD oil, the cannabis plant extract.
Mile High Labs welcomes findings from cannabis report
Mile High Labs has announced support for the findings in a Centre for Medicinal Cannabis report.
Why cannabidiol really is the next big thing
From the stories appearing about CBD and its near miraculous effects, to the pharmaceutical companies rushing to catch up, it seems everyone is taking about cannabidiol.
We need to talk about access to medical cannabis
Ramya Sriram, manager at Kolabtree, explains why many patients in the UK still cannot access medical cannabis and how scientific communication and further research can lead to change.
Marijuana use during pregnancy: The cannabis conundrum
Dennis R. Carty, Ph.D. and Pamela J. Lein, Ph.D., University of California, highlight the rising trend of marijuana use during pregnancy and the implications surrounding it.
Medicinal cannabis requires further clinical research and educational support
Dr Mark Ware, Chief Medical Officer at Canopy Growth, provides an overview of the research that already exists around medicinal cannabis and explains why there is a need to educate clinicians further.
Cannabis: One of the most thoroughly studied plants ever
David Bearman, M.D., Executive VP of the American Academy of Cannabinoid Medicine details the research priorities for cannabis, one of the most thoroughly studied plants of all time
